Narducci and Tosi et al_Front Immunol_2020 Sep 25

Raw data of experiments described in Fig.1 and Fig.4 of manuscript titled "Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab" by Narducci M.G. and Tosi A. et al. Frontiers in Immunology 2020 Sep 25;11:579894. doi: 10.3389/fimmu.2020.579894

本数据集为Narducci M.G.、Tosi A.等人发表于《免疫学前沿（Frontiers in Immunology）》2020年9月25日，第11卷，文章编号579894，DOI:10.3389/fimmu.2020.579894的题为《接受纳武利尤单抗（Nivolumab）治疗的黑色素瘤并发塞扎里综合征（Sezary Syndrome）患者的T淋巴瘤细胞（T Lymphoma Cells）减少与免疫功能增强（Immunological Invigoration）》的研究论文中，图1与图4所描述实验的原始数据。